Tianjin TEDA Biomedical Engineering Company Limited (Stock Code: 08189) released its monthly return for equity issuers covering the period ended 31 January 2026. The filing shows that the company’s total authorized share capital stood at RMB 213,390,000, consisting of 1,436,400,000 H shares and 697,500,000 domestic shares, each with a par value of RMB 0.1. There were no changes in the issued share capital, and the number of treasury shares remained at zero.

The company confirms compliance with the prescribed public float requirement of 25%. No new share options, warrants, convertibles, or any other agreements to issue shares were reported for the month, and no movements occurred in treasury shares. The filing was submitted on 02 February 2026.